The fundamental goal of this work is to improve our ability to optimize the overall plan for each patient's? treatment course (""""""""comprehensive"""""""" treatment course optimization). Current planning methods make use of? only a static single instance of the patient's anatomy (typically a treatment planning CT scan), and create an? optimized treatment plan based on the clinical therapy prescription, using interactive or inverse planning? optimization techniques (for Intensity Modulated Radiation Therapy (IMRT)). However, our knowledge of? the patient and treatment goals is not static, but dynamic. Throughout the patient's course of treatment, we? obtain new information on geometrical localization, inter- and intra-fraction motion, clinical response, and? the precision to which we can predict uncertainties in the data used for planning. To better account for and? utiltize this knowledge, the proposed research will develop and evaluate new paradigms for comprehensive? optimization of the entire treatment course, evaluating potential improvements over the single-instance? planning/optimization techniques which are widely used throughout the radiotherapy community. The? project will develop a planning/optimization framework for individualized optimization which incorporates? geometric, dosimetric, clinical and biological information as it becomes available (Aim 1), study? improvements in single-stage optimization procedures for the multi-criteria problems encountered in? therapy planning (Aim 2), and explicitly investigate multi-stage optimization methods for planning and? delivery of the entire treatment course (Aim 3). This project will show that development of plan optimization? strategies which 1) explicitly account for setup uncertainty and/or organ motion, 2) make use of updated? clinical, biological, dosimetric and geometric information to refine the plan, and 3) model and optimize? multi-stage adaptive therapy for the entire treatment course will better tailor the overall treatment plan to? each individual patient and predict improvements over the current static inverse plan generated once for? each patient.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA059827-13
Application #
7658876
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
13
Fiscal Year
2008
Total Cost
$390,031
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Ohri, Nitin; Tomé, Wolfgang A; Méndez Romero, Alejandra et al. (2018) Local Control After Stereotactic Body Radiation Therapy for Liver Tumors. Int J Radiat Oncol Biol Phys :
Mendiratta-Lala, Mishal; Gu, Everett; Owen, Dawn et al. (2018) Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 102:1063-1069
Wang, Shulian; Campbell, Jeff; Stenmark, Matthew H et al. (2018) A model combining age, equivalent uniform dose and IL-8 may predict radiation esophagitis in patients with non-small cell lung cancer. Radiother Oncol 126:506-510
Sapir, Eli; Tao, Yebin; Schipper, Matthew J et al. (2018) Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 100:122-130
Hawkins, Peter G; Boonstra, Philip S; Hobson, Stephen T et al. (2018) Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels. Transl Oncol 11:102-108
Sun, Yilun; Hawkins, Peter G; Bi, Nan et al. (2018) Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 100:107-114
Kong, Feng-Ming Spring; Li, Ling; Wang, Weili et al. (2018) Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer. Radiother Oncol :
Shilkrut, Mark; Sapir, Eli; Hanasoge, Sheela et al. (2018) Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases. Am J Clin Oncol 41:326-331
Jackson, William C; Tao, Yebin; Mendiratta-Lala, Mishal et al. (2018) Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys 100:950-958
Miften, Moyed; Vinogradskiy, Yevgeniy; Moiseenko, Vitali et al. (2018) Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys :

Showing the most recent 10 out of 289 publications